Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
In 2015, the pharmaceutical company Zosano Pharma conducted a Phase II trial on a glucagon patch to test the patch’s safety and efficiency. The small trial, which represented an important step forward towards getting FDA approval, yielded positive results. Researchers found that applying two glucagon patches was just as effective at combating hypoglycemia as two intramuscular injections of a glucagon solution.
http://insulinnation.com/treatment2/glucagon-patch-performs-well-in-phase-ii-trial/
http://insulinnation.com/treatment2/glucagon-patch-performs-well-in-phase-ii-trial/